THURSDAY, July 17, 2025 (HealthDay News) — Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is independently associated with less improvement in glucose homeostasis, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from […]
The post ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide first appeared on Physician’s Weekly.
